These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1882800)

  • 21. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis.
    Simko V; Michael S; Prego V
    Am J Gastroenterol; 1994 Mar; 89(3):392-8. PubMed ID: 8122652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
    Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases.
    Ballot E; Bandin O; Chazouilleres O; Johanet C; Poupon R
    J Autoimmun; 2004 Mar; 22(2):153-8. PubMed ID: 14987744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Calmus Y; Gane P; Rouger P; Poupon R
    Hepatology; 1990 Jan; 11(1):12-5. PubMed ID: 2403961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
    Lee YM; Kaplan MM
    Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid.
    Chen L; Borozan I; Milkiewicz P; Sun J; Meng X; Coltescu C; Edwards AM; Ostrowski MA; Guindi M; Heathcote EJ; McGilvray ID
    Liver Int; 2008 Aug; 28(7):997-1010. PubMed ID: 18422935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dipeptidyl-peptidase IV of human lymphocytes in patients with primary biliary cirrhosis and UDCA therapy].
    Kürktschiev D; Adler D; Subat S; Lehmann HU; Schentke KU
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():104-5. PubMed ID: 7483686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
    Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF
    Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate therapy for primary biliary cirrhosis.
    Bach N; Bodian C; Bodenheimer H; Croen E; Berk PD; Thung SN; Lindor KD; Therneau T; Schaffner F
    Am J Gastroenterol; 2003 Jan; 98(1):187-93. PubMed ID: 12526956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial.
    Papatheodoridis GV; Hadziyannis ES; Deutsch M; Hadziyannis SJ
    Am J Gastroenterol; 2002 Aug; 97(8):2063-70. PubMed ID: 12190178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
    Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
    Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?
    Lindor KD; Janes CH; Crippin JS; Jorgensen RA; Dickson ER
    Hepatology; 1995 Feb; 21(2):389-92. PubMed ID: 7843710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
    Wolfhagen FH; van Buuren HR; Schalm SW
    Neth J Med; 1994 Mar; 44(3):84-90. PubMed ID: 8202208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two successive pregnancies after ursodeoxycholic acid therapy in a previously infertile woman with antimitochondrial antibody-negative primary biliary cirrhosis.
    Korkut E; Kisacik B; Akcan Y; Belenli O; Bicik Z; Yucel O
    Fertil Steril; 2005 Mar; 83(3):761-3. PubMed ID: 15749512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.
    Heathcote EJ; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor KD; Petz J; Dickson ER; Poupon RE
    Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
    Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis].
    Avezov SA; Mansurov FKh
    Klin Med (Mosk); 2004; 82(3):55-8. PubMed ID: 15114777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.
    Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R
    Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.